SHARP: A stab in the right direction in chronic kidney disease

The Lancet

Volumn 377, Issue 9784, 2011, Pages 2153-2154

  Stevens, Kathryn K ^a   Jardine, Alan G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; EZETIMIBE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MONOTHERAPY; MORTALITY; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 79959707564     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60822-2     Document Type: Note

References (8)

1. C Baigent, MJ Landray, C Reith for the SHARP investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 2011 10.1016/S0140-6736(11)60739-3 published online June 9.
2. Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Lancet 376 2010 1670 1681
3. M Tonelli, C Isles, GC Curhan et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease Circulation 110 2004 1557 1563 (Pubitemid 39297976)
4. GF Strippoli, SD Navaneethan, DW Johnson et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 2008 645 651 (Pubitemid 351481234)
5. C Wanner, V Krane, W März for the German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
6. BC Fellström, AG Jardine, RE Schmieder for the AURORA Study Group Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
7. H Holdaas, B Fellstrom, AG Jardine for the Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031 (Pubitemid 36695044)
8. K Szummer, P Lundman, SH Jacobson et al. Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction Kidney Int 79 2011 997 1004